Nuvectis Pharma Inc. (NVCT)
Market Closed
16 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
18. 60
-0.33
-1.7433%
$
560.45M Market Cap
- P/E Ratio
- Div Yield
158,500 Volume
-1.52 Eps
$ 18.93
Previous Close 
Want to track NVCT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Nuvectis Pharma Inc. (NVCT) Statistics
Valuation metrics
Market Cap 560.45M
Enterprise value 538.29M
Trailing P/E (ttm) -16.12
Forward P/E -
PEG ratio 1.08
Price/Sales (ttm) -
Price/Book (mrq) 54.59
Enterprise Value/Revenue -
Enterprise Value/EBITDA -18.61
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 153K
Average volume (90 days) 219.86K
Price summary
52-Week low 5.55
52-Week high 29.27
Beta -
50-Day moving average 21.38
200-Day moving average 10.32
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.24%
Return on equity -1.69%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.19
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.94
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 1.68%
Book value per share (mrq) 0.39
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
